Unknown

Dataset Information

0

CD-1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.


ABSTRACT: AIMS/INTRODUCTION:To establish novel therapies to combat diabetic kidney disease, a human disease-relevant animal model is essential. However, a type 2 diabetic mouse model presenting progressive kidney fibrosis has not yet been established. Kidneys of streptozotocin-induced diabetic CD-1 mice showed severe fibrosis compared with other backgrounds of mice associated with the suppression of antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline. The BKS background (BKSdb / db ) is often utilized for diabetic kidney disease research; the kidney fibrosis in the BKSdb / db phenotype is minimal. MATERIALS AND METHODS:We generated CD-1db / db mice by backcrossing the db gene into the CD-1 background, and analyzed phenotypic differences compared with BKSdb / db and CD-1db / m mice. RESULTS:Male CD-1db / db mice appeared to have elevated blood glucose levels compared with those of BKSdb / db mice. Fasting insulin levels declined in CD-1db / db mice. Plasma cystatin C levels tended to be elevated in CD-1db / db mice from 16 to 24 weeks-of-age. Male CD-1db / db mice showed significantly progressive kidney and heart fibrosis from 16 to 24 weeks-of-age when compared with that of age-matched BKSdb / db mice. The gene expression profile showed fibrogenic program-associated genes in male CD-1db / db mice. Male CD-1db / db mice displayed significantly lower urine antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline when compared to that of BKSdb / db at 24 weeks-of-age. The gene expression of prolyl oligopeptidase, the enzyme essential for antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline production from thymosin ?4, was significantly lower in the CD-1 mice. Thymosin ?4 levels were also lower in CD-1 mice. CONCLUSIONS:These results suggest that CD-1db / db mice are a novel type 2 diabetic mouse model with progressive kidney and heart fibrosis.

SUBMITTER: Mizunuma Y 

PROVIDER: S-EPMC7610117 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD-1<sup>db/db</sup> mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.

Mizunuma Yuiko Y   Kanasaki Keizo K   Nitta Kyoko K   Nakamura Yuka Y   Ishigaki Yasuhito Y   Takagaki Yuta Y   Kitada Munehiro M   Li Shaolan S   Liu Haijie H   Li Jinpeng J   Usui Isao I   Aso Yoshimasa Y   Koya Daisuke D  

Journal of diabetes investigation 20200703 6


<h4>Aims/introduction</h4>To establish novel therapies to combat diabetic kidney disease, a human disease-relevant animal model is essential. However, a type 2 diabetic mouse model presenting progressive kidney fibrosis has not yet been established. Kidneys of streptozotocin-induced diabetic CD-1 mice showed severe fibrosis compared with other backgrounds of mice associated with the suppression of antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline. The BKS background (BKS<sup>db</sup> <s  ...[more]

Similar Datasets

| S-EPMC5292381 | biostudies-literature
| S-EPMC6761027 | biostudies-literature
2017-06-10 | GSE87359 | GEO
2016-10-24 | GSE77717 | GEO
| S-EPMC5955815 | biostudies-literature
2016-10-24 | E-GEOD-77717 | biostudies-arrayexpress
| S-EPMC6579681 | biostudies-literature
2021-09-29 | GSE184836 | GEO
2024-08-13 | GSE215291 | GEO
| S-EPMC4245833 | biostudies-literature